Research is vital to Cancer Council NSW and we are proud of our role in conducting and funding world-class research, which is possible because of the community.
Cancer Council NSW continues to be one of the largest non-government funders of cancer research in Australia, and in 2014/15, we provided $14.9 million in funding to support research.
Research experts, cancer patients, survivors and carers help us decide what research to fund. We assess both the scientific merit of a project and its potential impact on the community.
In 2015/16 Cancer Council NSW provided funding to support 77 world-class cancer research projects, with 229 researchers across 19 institutions.
Our researchers have underpinned major changes to Australia’s National Cervical Screening Program including the introduction of a new screening test which will reduce cervical cancer rates
Professor Minoti Apte and her team made a crucial breakthrough in finding that the cells around the pancreas help the tumour to grow. Targeting these cells can hinder growth of the cancer.
A diagnosis of pancreatic cancer 18 years ago drove Jan to improve her understanding of cancer. She now sits on our Research Consumer Review Panel, helping decide which research we fund.
Professor Christopher Ormandy is driving the next generation of revolutionary breast cancer treatments. His team has identified pathways that turn normal breast cells into cancer.
Teresa says cancer research is the reason she is here today, and every step is taking us closer to a cure. As a fundraiser, her driving motivation is to raise money for research.
Professor Robyn Ward and her team have discovered new causes of the hereditary condition, Lynch syndrome, which makes people more likely to get certain cancers.
Cancer Council researchers have found lung cancer rates for women are still rising. Calculating cancer trends provides vital data to help plan health care needs of future patients.
The Tackling Nicotine Together trial is integrating tobacco treatment with routine care in drug and alcohol clinics to help reduce the high smoking rates among patients.
A focus of Billie’s research has been on smoking in groups where smoking rates are highest, including people who are socio-economically disadvantaged, and those with chronic illnesses.
We found the number of men dying from prostate cancer in Australia is not declining at the rate seen in other countries. New projects are looking at ways to better manage prostate cancer.
David’s research is tracking the health of 2,000 men with prostate cancer to understand the long-term impact of this cancer and find ways to improve the lives of the men affected.
Professor Murray Norris and his team developed a pioneering tool that is improving the survival of children with leukaemia by stopping the cancer from returning.
One of Murray’s proudest achievements so far has been the development of unique technology that helps prevent relapse in children with acute lymphoblastic leukaemia.
Professor Xu Dong Zhang found the loss of a certain protein could cause melanoma to spread. When the team restored this protein back to normal levels, melanoma growth was stopped.
Our National Pro Bono service provides people affected by cancer with free legal and financial assistance, helping them to navigate the issues that come with a cancer diagnosis.
Professor Samuel Breit has unlocked a new way of stopping prostate cancer and other common cancers in their tracks through targeting a protein involved in tumour development.
For Phil, the highlight of being on the Consumer Review Panel is seeing the variety of different research proposals Cancer Council NSW receives on many different types of cancer.